Adding new drugs to insulin for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests whether adding certain diabetes pills (GLP-1 receptor agonists or SGLT inhibitors) to insulin is safe and helpful for adults with type 1 diabetes. Doctors will check your glucose monitor data to see how well this works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with type 1 diabetes
- Your doctor has prescribed a GLP-1 RA or SGLT inhibitor (like Ozempic, Jardiance, or similar) for any reason, and you have taken it for no more than one week at the time you join
- You use a continuous glucose monitor (CGM) and have CGM data from the past month that can be shared for the study
- You are willing and able to give your informed consent to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding a diabetes pill called pioglitazone to your current treatment (which includes an SGLT2 inhibitor and insulin) can lower your HbA1c (average blood sugar) further and prevent a dangerous rise in blood ketones, a byproduct that can cause serious complications. If it works, this combination may help improve blood sugar control in people with type 1 diabetes.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests whether a medication called an SGLT2 inhibitor is safe for people with type 1 diabetes. It aims to lower blood sugar without increasing the risk of dangerous complications.
This study looks at whether adding oral diabetes medications to insulin therapy can help people with type 1 diabetes manage their blood sugar better. It compares people who take both insulin and oral drugs with those who take only insulin.
This study tests whether adding a sodium-glucose cotransporter-2 inhibitor (SGLT2i), a thiazolidinedione (TZD), or a combination of both to your current DPP4 inhibitor-based treatment can improve blood sugar control in type 2 diabetes. It aims to find the best add-on option for people who need extra help managing their diabetes.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.